MyAverix Finance
US · Healthcare
RZONF (RZONF)
Biotechnology
RZONF (RZONF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for RZONF
P/E ratio
25.00
RZONF (RZONF) — FAQ
What is RZONF's P/E ratio?
The price-to-earnings (P/E) ratio for RZONF (RZONF) is 25.00 (data as of 2026-05-23).
Does RZONF pay a dividend?
Dividend yield is not available in the current snapshot for RZONF (RZONF). Check the MyAverix Finance app for the latest dividend data.
What sector is RZONF in?
RZONF (RZONF) is classified in the Healthcare sector (Biotechnology industry).
What exchange is RZONF listed on?
RZONF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.